ProShare Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.1K | Sell |
|
|||||
|
2025
Q1 | $84.5K | Sell |
|
|||||
|
2024
Q4 | $165K | Buy |
|
|||||
|
2024
Q3 | $115K | Buy |
|
|||||
|
2024
Q2 | $69.3K | Sell |
|
|||||
|
2024
Q1 | $240K | Buy |
|
|||||
|
2023
Q4 | $577K | Buy |
|
|||||
|
2023
Q3 | $415K | Buy |
|
|||||
|
2023
Q2 | $661K | Buy |
|
|||||
|
2023
Q1 | $558K | Buy |
|
|||||
|
2022
Q4 | $391K | Buy |
|
|||||
|
2022
Q3 | $254K | Sell |
|
|||||
|
2022
Q2 | $206K | Sell |
|
|||||
|
2022
Q1 | $586K | Sell |
|
|||||
|
2021
Q4 | $1.62M | Buy |
|
|||||
|
2021
Q3 | $1.84M | Sell |
|
|||||
|
2021
Q2 | $3.01M | Buy |
|
|||||
|
2021
Q1 | $2.51M | Buy |
|
|||||
|
2020
Q4 | $1.77M | Buy |
|
|||||
|
2020
Q3 | $483K | Buy |
|
|||||
|
2020
Q2 | $153K | Buy |
|
|||||
|
2020
Q1 | $90K | Sell |
|
|||||
|
2019
Q4 | $269K | Sell |
|
|||||
|
2019
Q3 | $297K | Sell |
|
|||||
|
2019
Q2 | $358K | Sell |
|
|||||
|
2019
Q1 | $479K | Buy |
|
|||||
|
2018
Q4 | $480K | Sell |
|
|||||
|
2018
Q3 | $372K | Sell |
|
|||||
|
2018
Q2 | $254K | Sell |
|
|||||
|
2018
Q1 | $154K | Sell |
|
|||||
|
2017
Q4 | $206K | Buy |
|
|||||
|
2017
Q3 | $379K | Buy |
|
|||||
|
2017
Q2 | $197K | Sell |
|
|||||
|
2017
Q1 | $303K | Sell |
|
|||||
|
2016
Q4 | $282K | Buy |
|
|||||
|
2016
Q3 | $590K | Sell |
|
|||||
|
2016
Q2 | $522K | Buy |
|
|||||
|
2016
Q1 | $571K | Sell |
|
|||||
|
2015
Q4 | $929K | Buy |
|
|||||
|
2015
Q3 | $230K | Sell |
|
|||||
|
2015
Q2 | $387K | Sell |
|
|||||
|
2015
Q1 | $413K | Buy |
|
|||||
|
2014
Q4 | $467K | Buy |
|
|||||
|
2014
Q3 | $291K | Sell |
|
|||||
|
2014
Q2 | $438K | Sell |
|
|||||
|
2014
Q1 | $530K | Buy |
|
|||||
|
2013
Q4 | $171K | Sell |
|
|||||
|
2013
Q3 | $295K | Buy |
|
|||||
|
2013
Q2 | $95K | Buy |
|